Posted in | News | Lighting

Federal Signal Divests Industrial Lighting Manufacturing Unit to Cooper Crouse-Hinds

Federal Signal Corporation (NYSE: FSS), a leader in advancing security and well-being for communities and workplaces around the world, today announced it has completed the sale of its industrial lighting manufacturer subsidiary, Pauluhn, to the Cooper Crouse-Hinds division of Cooper Industries plc (NYSE: CBE) for $35 million.

William Osborne, president and chief executive officer, stated, "We are pleased to have completed the sale of Pauluhn to Cooper Industries. This transaction is part of our ongoing efforts to streamline and focus Federal Signal's business portfolio, while enhancing our financial flexibility. We intend to invest the proceeds from the sale transaction in growth opportunities faced by our public safety businesses."

Mr. Osborne continued, "We greatly appreciate the many contributions and hard work by all Pauluhn employees, led by Wilfred Bullock. Pauluhn is a good fit with Cooper Industries and I am confident that Pauluhn will continue to deliver the high-quality products and service their customers have come to expect from them. We wish them continued success." Wilfred Bullock will continue with Federal Signal to ensure a smooth transition.

For over 75 Years Pauluhn has been providing marine, offshore and industrial lighting products with innovative solutions for hazardous locations and corrosive environments. Pauluhn is a leading supplier of a wide range of specialized area lighting and connecting products used in offshore and onshore drilling, shipbuilding, mining, petrochemical and other industrial applications involving harsh and corrosive environments.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.